{"paper_id":"1c0af6d8-1e91-45f0-b1fa-2f8c1cd36c45","body_text":"Abstract\nAdenomyosis (ADS) is a common benign gynecological disease. Abnormal proliferation at the endometrial-myometrial interface (EMI) plays a crucial role in the occurrence and progression of ADS. miR-141-3p is associated with cell proliferation and apoptosis. However, the specific mechanism of miR-141-3p in the etiology of ADS is still unknown. In this study, we explored the effects of miR-141-3p on the proliferation and apoptosis of ADS EMI smooth muscle cells (SMCs). We collected EMI tissues for the primary culture of SMCs from 25 patients diagnosed with ADS and 20 without ADS. Real-time quantitative polymerase chain reaction and western blot were used to measure the mRNA and protein expression levels of miR-141-3p, JAK2, STAT3, phospho-JAK2, and phospho-STAT3 in ADS EMI SMCs. The cell counting kit 8 assay and flow cytometry analysis were used to evaluate the proliferation and apoptosis of EMI SMCs. The miR-141-3p mimic/inhibitor was used to increase or decrease the expression level of miR-141-3p. We added WP1066 to block the phosphorylation of JAK2/STAT3 pathway components. The miR-141-3p levels were decreased, while JAK2 and STAT3 levels were increased in ADS EMI SMCs. miR-141-3p overexpression significantly inhibited the proliferation and enhanced the apoptosis of EMI SMCs, whereas a decrease in miR-141-3p expression level was connected to the opposite results. Meanwhile, inactivated JAK2/STAT3 pathway decreased proliferation and enhanced apoptosis of EMI SMCs after WP1066 treatment. Furthermore, rescue experiments confirmed that the JAK2/STAT3 pathway was the downstream pathway of miR-141-3p and reduced the effect of miR-141-3p on the proliferation and apoptosis of EMI SMCs. These results demonstrate that miR-141-3p regulates the proliferation and apoptosis of ADS EMI SMCs by modulating the JAK2/STAT3 pathway.\nSimilar content being viewed by others\nData Availability\nSupporting and raw data are available upon a reasonable request to the corresponding author.\nAbbreviations\n- ADS:\n-\nadenomyosis\n- EMI:\n-\nendometrial-myometrial interface\n- SMCs:\n-\nsmooth muscle cells\n- JAK2:\n-\nThe Janus Kinase2\n- STAT3:\n-\nsignal transducer and activator of transcription3\n- p-JAK2:\n-\nphosphorylated The Janus Kinase2\n- p-STAT3:\n-\nphosphorylated signal transducer and activator of transcription3\n- α-SMA:\n-\nalpha-smooth muscle actin\n- RT-qPCR:\n-\nreal-time quantitative polymerase chain reaction\n- CCK-8:\n-\ncell counting kit-8\nReferences\nAndreasen S, Therkildsen MH, Grauslund M, Friis-Hansen L, Wessel I, Homøe P (2015) Activation of the interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland. APMIS 123(8):706–715. https://doi.org/10.1111/apm.12407\nBao W, Wang HH, Tian FJ, He XY, Qiu MT, Wang JY, Zhang HJ, Wang LH, Wan XP (2013) A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 12:155. https://doi.org/10.1186/1476-4598-12-155\nBrosens JJ, Barker FG, de Souza NM (1998) Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterus. Hum Reprod Update 4(5):496–502. https://doi.org/10.1093/humupd/4.5.496\nCao M, Tian K, Sun W, Xu J, Tang Y, Wu S (2022) MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway. Exp Ther Med 23(1):97. https://doi.org/10.3892/etm.2021.11020\nChen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, Song K, Xu RH (2021) The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer 20(1):166. https://doi.org/10.1186/s12943-021-01475-8\nCui Z, An X, Li J, Liu Q, Liu W (2018) LncRNA MIR22HG negatively regulates mir-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation. Biomed Pharmacother 104:223–228. https://doi.org/10.1016/j.biopha.2018.05.046\nFusi L, Cloke B, Brosens JJ (2006) The uterine junctional zone. Best Pract Res Clin Obstet Gynaecol 20(4):479–491. https://doi.org/10.1016/j.bpobgyn.2006.02.001\nGarcía-Solares J, Donnez J, Donnez O, Dolmans MM (2018) Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril 109(3):371–379. https://doi.org/10.1016/j.fertnstert.2017.12.030\nGu M, Liu C, Yang T, Zhan M, Cai Z, Chen Y, Chen Q, Wang Z (2021) High-Fat Diet Induced Gut Microbiota alterations associating with Ghrelin/Jak2/Stat3 Up-Regulation to promote Benign Prostatic Hyperplasia Development. Front Cell Dev Biol 9:615928. https://doi.org/10.3389/fcell.2021.615928\nGuo SW (2020) The pathogenesis of adenomyosis vis-à-vis endometriosis. J Clin Med 9(2):485. https://doi.org/10.3390/jcm9020485\nHuynh J, Etemadi N, Hollande F, Ernst M, Buchert M (2017) The JAK/STAT3 axis: a comprehensive drug target for solid malignancies. Semin Cancer Biol 45:13–22. https://doi.org/10.1016/j.semcancer.2017.06.001\nJaśkiewicz A, Domoradzki T, Pająk B (2020) Targeting the JAK2/STAT3 pathway-can we compare it to the two faces of the God Janus? Int J Mol Sci 21(21):8261. https://doi.org/10.3390/ijms21218261\nJohnson DE, O’Keefe RA, Grandis JR (2018) Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234–248. https://doi.org/10.1038/nrclinonc.2018.8\nLeyendecker G, Wildt L (2011) A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Horm Mol Biol Clin Investig 5(2):125–142. https://doi.org/10.1515/HMBCI.2011.002\nLeyendecker G, Wildt L, Mall G (2009) The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 280(4):529–538. https://doi.org/10.1007/s00404-009-1191-0\nLiu Y, Lin W, Dong Y, Li X, Lin Z, Jia J, Zou W, Pan Y Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer. Cancer Med, 9(18), 6752–6765., Mehasseb MK, Bell SC, Pringle JH, Habiba MA (2020). Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril, 93(7), 2130–2136. https://doi.org/10.1016/j.fertnstert.2009.01.097\nMengie Ayele T, Tilahun Muche Z, Behaile Teklemariam A, Bogale Kassie A, Abebe C, E (2022) Role of JAK2/STAT3 signaling pathway in the Tumorigenesis, Chemotherapy Resistance, and treatment of solid tumors: a systemic review. J Inflamm Res 15:1349–1364. https://doi.org/10.2147/JIR.S353489\nOh-Hohenhorst SJ, Lange T (2021) Role of metastasis-related microRNAs in prostate Cancer progression and treatment. Cancers (Basel) 13(17):4492. https://doi.org/10.3390/cancers13174492\nPhatak P, Noe M, Asrani K, Chesnick IE, Greenwald BD, Donahue JM (2021) MicroRNA-141-3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1. Mol Carcinog 60(2):125–137. https://doi.org/10.1002/mc.23274\nSchmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108. https://doi.org/10.1038/nprot.2008.73\nSun S, Ma J, Xie P, Wu Z, Tian X (2020) Hypoxia-responsive mir-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway. J Gene Med 22(10):e3230. https://doi.org/10.1002/jgm.3230\nTong SJ, Zhang XY, Guo HF, Yang J, Qi YP, Lu S (2021) Study on effects of mir-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2. Clin Transl Oncol 23(12):2526–2535. https://doi.org/10.1007/s12094-021-02653-2\nWang D, Luo Y, Wang G, Yang Q (2020) CircATRNL1 promotes epithelial-mesenchymal transition in endometriosis by upregulating yes-associated protein 1 in vitro. Cell Death Dis 11(7):594. https://doi.org/10.1038/s41419-020-02784-4\nXu Y, Xu X, Gao X, Chen H, Geng L (2014) Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2/STAT3 pathway. Int Immunopharmacol 19(2):327–333. https://doi.org/10.1016/j.intimp.2014.01.027\nXu J, Wang H, Wang H, Chen Q, Zhang L, Song C, Zhou Q, Hong Y (2019) The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1. Hereditas 156:11. https://doi.org/10.1186/s41065-019-0087-7\nYan YR, Luo Y, Zhong M, Shao L (2019) MiR-216a inhibits proliferation and promotes apoptosis of human airway smooth muscle cells by targeting JAK2. J Asthma 56(9):938–946. https://doi.org/10.1080/02770903.2018.1509991\nZhai J, Vannuccini S, Petraglia F, Giudice LC (2020) Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med 38(2–03):129–143. https://doi.org/10.1055/s-0040-1716687\nZhang Y, Yan J, Pan X (2019) Mir-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12. Pflugers Arch 471(8):1055–1063. https://doi.org/10.1007/s00424-019-02283-2\nZhang H, Tan M, Zhang J, Han X, Ma Y (2021) Propofol Inhibits Thyroid Cancer Cell Proliferation, Migration, and Invasion by Suppressing SHH and PI3K/AKT Signaling Pathways via the miR-141-3p/BRD4 Axis. J Healthc Eng, 2021, 2704753. https://doi.org/10.1155/2021/2704753\nZhong Y, Yin B, Ye Y, Dekhel OYAT, Xiong X, Jian Z, Gu L (2021) The bidirectional role of the JAK2/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury. Exp Neurol 341:113690. https://doi.org/10.1016/j.expneurol.2021.113690\nZhou D, Gu J, Wang Y, Wu H, Cheng W, Wang Q, Zheng G, Wang X (2021) Long non-coding RNA NEAT1 transported by extracellular vesicles contributes to breast cancer development by sponging microRNA-141-3p and regulating KLF12. Cell Biosci 11(1):68. https://doi.org/10.1186/s13578-021-00556-x\nAcknowledgements\nWe would like to thank to Medical Research Center, Beijing Chao-Yang Hospital for providing us with the experimental platform.\nFunding\nThis study was funded by National Natural Science Foundation of China (No. 81571412).\nAuthor information\nAuthors and Affiliations\nContributions\nSirui Wang drafted the manuscript, completed all the experiments and analyzed the data of the study. Hua Duan participated in the study design and revised the manuscript. Sha Wang helped to analyze the experimental data. Zhengchen Guo and Qi Lin helped with collection of tissue samples and acquisition of data. All authors approved the final version of the manuscript.\nCorresponding author\nEthics declarations\nEthics Approval and Consent to Participate\nThis study was authorized by the Ethics Committee of our hospital (No. 2016-KY-012-02). All patients signed an informed consent form before the hysterectomy.\nConsent for Publication\nNot applicable.\nCompeting Interests\nThe authors declare that they have no known competing interests that could have appeared to influence the work reported in this paper.\nAdditional information\nPublisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nSpringer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.\nAbout this article\nCite this article\nWang, S., Duan, H., Wang, S. et al. miR-141-3p Regulates the Proliferation and Apoptosis of Endometrial-Myometrial Interface Smooth Muscle Cells in Adenomyosis Via JAK2/STAT3 Pathway. Biochem Genet 62, 2049–2065 (2024). https://doi.org/10.1007/s10528-023-10508-4\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s10528-023-10508-4","source_license":"CC0","license_restricted":false}